Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.

EverQuote, Hims & Hers, and Sprouts shine with standout earnings surprises and strong DuPont-driven fundamentals.

Needham upped the price objective on Hims & Hers Health, Inc. (NYSE:HIMS)’s stock to $65 from $61, while maintaining a “Buy” ...

Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market ...

The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Tuesday after the company announced an acceleration of its ...

Hims & Hers Health will acquire Zava, expanding the company’s services to Ireland, France and Germany and growing its active ...

The E.U.’s universal healthcare policies make pharmaceuticals much more affordable relative to the U.S., meaning there could ...

Hims & Hers expanding in Europe with the purchase of London-based digital health platform ZAVA. The acquisition gives the ...

Dollar General ( DG) was the best-performing stock in the S&P 500 after the discount retailer beat profit and sales estimates ...

Tuesday, online health and wellness company Hims & Hers announced its intent to acquire European digital healthcare provider ...

Hims & Hers Health agreed to acquire Zava, a digital health platform in Europe. The telehealth-consultation platform said its acquisition will expand its footprint into the United Kingdom and ...